In an animal model of retinopathy of prematurity (ROP), SB-267268 decreased the mRNA expressions of VEGF and VEGFR2, and reduced the pathological angiogenesis by 50% [189]. This evidence concerns the gene VEGFA and retinopathy of prematurity.